
|Articles|August 11, 2021
Pharmacy Clinical Pearl of the Day: First-line Treatment Options for Heart Disease
Author(s)Saro Arakelians, PharmD
The goal of treating heart failure is to reduce symptoms, improve heart function, and increase ejection fraction.
Advertisement
Clinical Pearl of the Day:
Heart failure disease first-line treatment options:
- ACE inhibitors/ARB or ARNI (Entresto) and Beta blockers plus aldosterone blockers (for Class II-IV heart failure with GFR>30ml, K+<5)
- SGLT-2 Inhibitor: If volume is overloaded add Loop diuretic
Explanation:
When it comes to heart failure treatment options, patients should be started on beta blockers, ACE inhibitors, ARBs, or ARNIs.
If the dosages are maxed out, patients do not tolerate, or patients do not benefit from these first-line options, then prescribers should be adding aldosterone blockers or SGLT-2 inhibitors
The goal is to reduce the symptoms, improve heart function, and increase ejection fraction.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
4
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
5




























































































































